Skip to main content
mSystems logoLink to mSystems
. 2020 Jan 14;5(1):e00827-19. doi: 10.1128/mSystems.00827-19

Galacto-Oligosaccharides Modulate the Juvenile Gut Microbiome and Innate Immunity To Improve Broiler Chicken Performance

Philip J Richards a, Geraldine M Flaujac Lafontaine a, Phillippa L Connerton a, Lu Liang a, Karishma Asiani a, Neville M Fish b, Ian F Connerton a,
Editor: David W Clearyc
PMCID: PMC6967391  PMID: 31937680

Improvements in the growth rate of broiler chickens can be achieved through dietary manipulation of the naturally occurring bacterial populations while mitigating the withdrawal of antibiotic growth promoters. Prebiotic galacto-oligosaccharides (GOS) are manufactured as a by-product of dairy cheese production and can be incorporated into the diets of juvenile chickens to improve their health and performance. This study investigated the key mechanisms behind this progression and pinpointed L. johnsonii as a key species that facilitates the enhancements in growth rate and gut health. The study identified the relationships between the GOS diet, L. johnsonii intestinal populations, and cytokine immune effectors to improve growth.

KEYWORDS: prebiotic, galacto-oligosaccharides, chicken, microbiome, gut health, synbiotic, innate immunity, IL-17A

ABSTRACT

Improvements in growth performance and health are key goals in broiler chicken production. Inclusion of prebiotic galacto-oligosaccharides (GOS) in broiler feed enhanced the growth rate and feed conversion of chickens relative to those obtained with a calorie-matched control diet. Comparison of the cecal microbiota identified key differences in abundances of Lactobacillus spp. Increased levels of Lactobacillus johnsonii in GOS-fed juvenile birds at the expense of Lactobacillus crispatus were linked to improved performance (growth rate and market weight). Investigation of the innate immune responses highlighted increases of ileal and cecal interleukin-17A (IL-17A) gene expression counterposed to a decrease in IL-10. Quantification of the autochthonous Lactobacillus spp. revealed a correlation between bird performance and L. johnsonii abundance. Shifts in the cecal populations of key Lactobacillus spp. of juvenile birds primed intestinal innate immunity without harmful pathogen challenge.

IMPORTANCE Improvements in the growth rate of broiler chickens can be achieved through dietary manipulation of the naturally occurring bacterial populations while mitigating the withdrawal of antibiotic growth promoters. Prebiotic galacto-oligosaccharides (GOS) are manufactured as a by-product of dairy cheese production and can be incorporated into the diets of juvenile chickens to improve their health and performance. This study investigated the key mechanisms behind this progression and pinpointed L. johnsonii as a key species that facilitates the enhancements in growth rate and gut health. The study identified the relationships between the GOS diet, L. johnsonii intestinal populations, and cytokine immune effectors to improve growth.

INTRODUCTION

The production of poultry for both meat and eggs has been increasing rapidly throughout the world (1), and the global poultry sector is expected to continue to grow as a result of growing population, rising income, and urbanization (2). In this context, animal performance and feed conversion efficiency of fast-growing birds are decisive to the economic profitability of poultry meat production. Broiler chicken production is more sustainable and has a relatively lower environmental impact than other meat-based protein production (3). There have been massive increases in the growth rate and feed efficiency of broiler chickens since the 1940s, achieved largely through selective breeding and feed optimization (4). It is generally recognized that increases in performance are slowing as the advances made possible through these approaches are reaching their biological limit (5). The inclusion of antimicrobial growth promoters (AGPs), a practice banned in the European Union (EU) since 2006, is another way in which gains in productivity have been realized. The EU ban was imposed due to increasing concerns regarding the development of antimicrobial resistance and the transference of antibiotic resistance genes from animal to human microbiota (6). Although antimicrobials are still widely used, there have been reductions in the therapeutic use of antimicrobials in poultry production, which have led to an increase in intestinal health problems (7). To mitigate the effect of antimicrobial reduction a variety of strategies has been evaluated (8). These include the addition of dietary prebiotic (9, 10), the use of phytobiotic dietary additives (11), the incorporation of beneficial enzymes in poultry feed (12), and the administration of live probiotic bacteria in various combinations of the above (13). Recent developments in sequencing technologies have led to a greater understanding of the mechanisms and effects of these treatments on the gut microbiota and the interaction with host-related functions involved in intestinal health (14, 15). It has been proposed that further improvements to broiler performance could be sought through deliberate cultivation of a beneficial gut microbiota in early development (7, 16). These bacteria are preferably autochthonous and mutualists in association with each other and their host.

Galacto-oligosaccharides (GOS) are nondigestible carbohydrates that have been shown to promote beneficial autochthonous bacteria, such as Bifidobacterium, Bacteroides, and Lactobacillus. GOS are synthesized from lactose by β-galactosidase-catalyzed transglycosylation to create molecules of differing lengths and linkage types (17, 18). Several studies have reported that GOS can improve the performance of poultry and produce profound differences in desirable bacterial groups inhabiting the gut (19, 20).

Maintenance and enhancement of gut health are essential for the welfare and productivity of animals (21). In addition to nutrient digestion and absorption, the intestinal mucosa constitutes a physical and immunological protective barrier for the integrity of the intestinal tract (22). Mutualistic commensals with immunomodulotary effects (autobionts) affect the development and function of various immune cell populations, such as regulatory T cells (Tregs), Th17 T-helper cells, IgA-secreting plasma cells, natural killer (NK) cells, macrophages, dentritic cells (DCs), and innate lymphoid cells (ILCs) (23). Interleukin-17-producing CD4+ T lymphocytes (Th17 cells) contribute to host defense against pathogens and maturation of the immune response at an early age. Regulatory T cells play critical roles in immune suppression (24, 25), and thus, optimum health is achieved through a balanced regulation of expression between Th17 cells and Tregs.

There is little systematic information regarding the interaction between prebiotic diet, performance, structure of gut microbiota, and host gene expression in poultry. In this study, the impact of a GOS diet was assessed in broiler chickens by comparing a cohort fed a control diet and a cohort fed a GOS diet from day of hatch until 35 days of age (da), corresponding to a typical commercial farm rearing period. Ancillary dietary trials were carried out to confirm the reproducibility of the beneficial effects. The innate immune responses to the two diets were assessed in ileal and cecal tissue biopsy specimens by quantification of the relative expression of cytokine and chemokine gene transcription. Analysis of metagenomic profiles of GOS-fed birds enabled the identification and isolation of autochthonous synbiotic organisms. Characterization of these isolates allowed an in-depth analysis of the effect of the GOS diet and synbiotic species abundance on bird performance and gut health.

RESULTS

GOS supplementation improves the growth performance of broiler chickens.

Chickens fed a galacto-oligosaccharide (GOS)-supplemented diet performed better than those fed an isocaloric control diet (Fig. 1A). An increase in growth rate was apparent for the GOS-fed birds, which exhibited an increase in the mean live weight of 87.7 g/day, compared to 76.3 g/day for the control birds, calculated at between 8 and 35 days of age (da) (P = 0.012). Correspondingly, the mass of GOS-fed birds in trial 1 was greater than that of control birds at the slaughter age of 35 days (GOS-fed birds, 2,582 g; control birds, 2,336 g; P = 0.041 [Fig. 1B]). Two ancillary trials were carried out to demonstrate whether after removing the prebiotic once the microbiota was established on the GOS feed the beneficial effects on performance could be reproduced in mature birds. In these trials, the birds were either housed in individual cages (trial 2) or cohoused in 10 pens containing 3 birds (trial 3). The enhanced performance on the GOS-supplemented diet was evidenced by greater masses at 35 da in trial 2 (GOS-fed birds, 2,584 g; control birds, 1,838 g; P < 0.001 [Fig. 1C]) and trial 3 (GOS-fed birds, 2,501 g; control birds, 2,291 g; P = 0.057 [Fig. 1D]). Although trial 3 marginally failed to meet significance, the trend remained the same, with the GOS diet producing beneficial effects on growth when the birds were reared in pens. The feed conversion ratios (FCR) varied between trials but were reduced for birds on the GOS diets compared to the corresponding control groups (Fig. 1B to D). The zootechnical performance data for all trials are summarized in Table S1 in the supplemental material; they repeatedly show significantly greater weights for the GOS-fed juvenile birds over those on the control diet reared under similar circumstances at 35 da.

FIG 1.

FIG 1

Galacto-oligosaccharide diet improves the growth performance of broiler chickens. (A) GOS diet trial 1 comparing median body weight of birds fed the GOS diet with that of birds fed the control (ctl) diet. Data presented are for the mass observations made for the 10 birds from each cohort that remained at 35 days and hence were recorded throughout the trial. The contemporary male Ross 308 broiler chicken performance objective weight progression (96) is indicated by the gray dashed line. Panel B shows a box-and-whisker plot of the bird weights for trial 1 at 35 da. Panels C and D show box-and-whisker plots of the bird weights at 35 da for ancillary GOS diet trials 2 and 3 to demonstrate that the birds on the GOS diet consistently achieved greater body weight at 35 da than birds provided with a calorie-matched control diet. For reference, the contemporary male Ross 308 performance objective at 35 da is indicated by a horizontal dashed black line in each panel (96). Comparisons were made of mean weights using Student’s t test, with the corresponding P values reported above the diet pairs and the corresponding cumulative feed conversion ratios (FCR) indicated in the bottom right-hand side of each trial panel.

TABLE S1

Growth performance of broiler chickens raised on GOS-supplemented feed. Download Table S1, DOCX file, 0.03 MB (29.3KB, docx) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Lactobacillus spp. distinguish microbial communities colonizing the ceca of broiler chickens on GOS-supplemented diets.

Cecal bacterial communities were surveyed using 16S rRNA gene sequences. Analysis of trial 1 showed that the α-diversities of the cecal microbiota were not significantly different between GOS and control diet cohorts sampled at 8, 15, 22, and 35 da (inverse Simpson index, P ≥ 0.295; Shannon diversity, P ≥ 0.187 [Fig. S1A and B]). Community richness (Chao) was not significantly different throughout the trial (P ≥ 0.101 [Fig. S1C]). Communities of cecal bacteria colonizing birds on control and GOS diets could not be distinguished on the basis of Bray-Curtis dissimilarity at any age (P > Bonferroni correction for pairwise error [Fig. S1D]).

FIG S1

Diversity of the cecal microbiota on GOS and control diets. Panels A to C show indices of α-diversity of cecal bacterial populations for broiler chickens on GOS (gold) and control (black/white) diets sampled through the rearing period (8 to 35 da). Panel D shows NMDS plots of Bray-Curtis dissimilarity indices for all birds at all sample days. Age-matched cecal microbial communities could not be distinguished at any time point (pairwise error rate [Bonferroni] > 0.0017). Download FIG S1, TIF file, 2.9 MB (2.9MB, tif) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

The top 10 operational taxonomic units (OTUs) with the greatest relative abundances are shown in Fig. 2A for all the birds sampled at each time point. Figure 2B shows family level taxonomy to confirm the similarity between the cecal bacterial communities of birds fed control and GOS diets. However, few OTUs were discriminative between the control and GOS diets (Fig. 2C). Two OTUs, OTU0006 and OTU0010, identified as Lactobacillus spp., were discriminatory of the different diets in the early rearing period up to 15 da (OTU0006, P ≤ 0.01; OTU0010, P ≤ 0.022). Reads representing these OTUs accounted for 84.5% of those assigned to the Lactobacillales order and 86.1% assigned to the Lactobacillaceae family (Fig. 2B). The third major Lactobacillus species is represented by OTU0017, which together with OTU0006 and OTU0010 constitutes 99.95% of the Lactobacillaceae. Organisms exhibiting 16S rRNA gene V4 region sequence identity with the differential OTUs identified from 16S rRNA community analysis were isolated from MRS culture media. The genomic DNA sequences of these isolates were assembled from data generated on Illumina MiSeq and PacBio RSII platforms. Two representative isolates were designated L. crispatus DC21.1 (OTU0006) and L. johnsonii DC22.2 (OTU0010) based on whole-genome alignments with type strains available in public nucleotide sequence databases.

FIG 2.

FIG 2

Dietary GOS shifts the abundance of specific taxa. Panels A and B show stacked bar charts indicating the relative abundance to OTU (A) and family (B) levels of the cecal microbiota of birds fed GOS and control diets. In three cases, the sequence data sets did not meet pre- or postprocessing quality thresholds and were removed from the analysis (GOS samples at 8, 15, and 35 da). Panel C shows the differential bacterial species identified in cecal contents from birds fed the control diet and GOS diet analyzed using linear discriminant analysis effect size (LEfSe). Prior to analysis, age-matched communities were filtered to include only OTUs at ≥1% relative abundance. The linear discriminant analysis (LDA) threshold was set at 2, and the P value threshold was set at 0.05. Panel D shows box-and-whisker plots of the genome copy numbers of OTU0006 and OTU0010 per gram of cecal content determined using qPCR. Data are reported for genome numbers identified in birds fed GOS and control diets. Significant differences are indicated by P values above the sample pairs.

Quantitative PCR assays were developed to measure the absolute abundances of L. johnsonii (OTU0010) and L. crispatus (OTU0006) within the gut microbiota. Oligonucleotide primers were designed on the groEL gene sequences, as they have been frequently used to discriminate between Bifidobacterium strains with a high degree of sequence similarity (26, 27). Once validated, using spiked cecal samples, the technique was used to enumerate L. johnsonii (OTU0010) and L. crispatus (OTU0006) organisms within the cecal contents of control and GOS-fed birds. The genome copies of each isolate were measured throughout the rearing period. The results of these analyses confirmed the relative abundance estimates from metagenomic data in trial 1 and demonstrated that the abundances of these two OTUs show positive and negative associations with the GOS diet compared to the control diet (Fig. 2C). Notably, the abundance of L. crispatus (OTU0006) in the GOS-fed birds at 8, 15, and 22 da was significantly lower than in control birds (P < 0.048), and conversely, the abundance of L. johnsonii (OTU0010) was significantly greater at 8 da in the GOS-fed birds (P = 0.001).

Characteristics of the Lactobacillus spp. distinguishing the cecal communities.

Summaries of the functional gene contents of the L. johnsonii DC22.2 and L. crispatus DC21.1 isolates with respect to GOS utilization and host colonization are presented in Table 1. L. johnsonii and L. crispatus have the capacity to colonize and compete in the host intestine with genes encoding multiple mucus binding proteins (28), fibronectin binding proteins (28), exopolysaccharide biosynthesis (29), and bile salt hydrolase (30). L. johnsonii carries the apf gene (aggregation promoting factor), which encodes a cell surface protein that has been assigned a role in cell adhesion (31). L. crispatus contains the cbsA gene, which encodes the structural protein that forms the S-layer (32, 33). L. johnsonii and L. crispatus both encode the bacteriocin helveticin J and multiple bacteriocin immunity factors.

TABLE 1.

Summary of the functional gene contents of L. johnsonii and L. crispatus isolates related to GOS utilization and host colonization

Gene(s) L. johnsonii locus tag E6A54_ L. crispatus locus tag E6A57_ Function Reference
lacS 06610a 07265 Lactose permease 41
lacA 06605 07260 β-Galactosidase 41
lacL/M 06620 07275 β-Galactosidase 34
06625 07280
lacE/F O7225 PTS lactose transporter 34
lacG Phospho-β-galactosidase 34
mucBP 04955 06095 Adhesion 28
08660a 07570
09625 08180
01350
fbpA 04640 05230 Adhesion 28
cbsA/B 00840 S-layer 32
apf1/2 07620 Aggregation factor 31
epsA–E 05690–05730 08695–08755 Exopolysaccharide 29
Bacteriocin leader 09005 Bacteriocin 28
hlv 02750 00185 Helveticin J 28
05290
07800
10185
bsh 00415 08515 Bile salt hydrolase 30
a

Internal stop codons present.

There are ostensibly two pathways to utilize GOS that rely upon the cellular transporters LacS (lactose permease) and LacE/F (lactose phosphotransferase system); LacS permease appears to be capable of transporting GOS with degrees of polymerization of 2 to 6 (DP2 to DP6), but the LacE/F phosphotransferase is confined to DP2 lactose (34). The genome sequence of L. johnsonii DC22.2 suggests that the isolate could be impaired in GOS utilization. The lacS permease gene has a stop codon at the 17th position, which would require that the protein be initiated from an internal AUG with the loss of the first 31 amino acids compared to the majority of database homologues. In contrast, L. crispatus DC21.1 retains functional lacS and lacA genes to facilitate the use of GOS.

To assess the ability of the L. crispatus and L. johnsonii isolates to utilize GOS in axenic culture, the organisms were cultured in MRS basal medium containing DP2+ GOS in the absence of monosaccharides. Cultures were incubated for 72 h under anaerobic conditions at 37°C in basal medium with either DP2+ GOS (0.5% [wt/vol]) or glucose (0.5% [wt/vol]) as a positive control or sterile water instead of the carbon source as negative control (blank). Figure 3 shows growth of the isolates and Lactobacillus type strains indicated by the measurements of optical density at 600 nm (OD600) corrected for the negative control. L. crispatus DC21.1 utilizes GOS, showing increased growth over that recorded for L. fermentum ATCC 33323 in a parallel culture. Under these conditions L. johnsonii does not efficiently use GOS, which is consistent with the putative gene content but at odds with the differential abundance observed in the ceca of GOS-fed birds.

FIG 3.

FIG 3

In vitro growth of lactobacilli on galacto-oligosaccharides. Utilization of DP2+ GOS by L. crispatus DC21.1 and L. johnsonii DC22.2 isolates compared with that by Lactobacillus type strains is shown. Anaerobic growth was recorded from OD600 measurements after incubation with basal medium that was subtracted from that obtained by incubation with basal medium plus DP2+ GOS or glucose as a carbon source.

In-feed GOS effects on gut architecture.

Hematoxylin-eosin (H&E) stains of ileal histological sections did not exhibit any significant differences in heterophil infiltration or inflammatory characteristics between control and GOS-fed birds at any time in the experiment. The measurements of villus length and crypt depth indicate that GOS-fed juvenile birds at 15 da had longer villi (P = 0.05) and deeper crypts (P = 0.02) than birds on the control diet (Table 2). However, these differences did not result in a difference in the villus/crypt ratio. At 22 and 35 da, there were no significant morphometric differences recorded. Goblet cell densities of villi from control and GOS-fed birds were evaluated from periodic acid-Schiff (PAS)-stained (neutral mucin-producing) ileal sections (Table 2). Greater densities of goblet cells were observed from GOS-fed birds sampled throughout trial 1, with significant differences recorded at days 8 (P = 0.04), 15 (P = 0.002), and 22 (P = 0.04).

TABLE 2.

Ileal gut morphometrics: villus length, crypt depth, and goblet cell density

Diet or parameter and age (days) Villus length (μm) Crypt depth (μm) Ratio villus/crypt Goblet/mm2
Control diet
    8 475 ± 64 75 ± 7 6.3 ± 0.9 1,457 ± 347
    15 615 ± 70 103 ± 11 6.0 ± 0.5 1,198 ± 140
    22 747 ± 167 126 ± 20 5.9 ± 0.4 1,378 ± 290
    35 731 ± 110 121 ± 17 6.0 ± 0.3 1,267 ± 243
GOS diet
    8 505 ± 63 79 ± 7 6.0 ± 0.8 1,707 ± 212
    15 676 ± 93 113 ± 13 5.9 ± 0.5 1,450 ± 247
    22 687 ± 118 118 ± 18 5.8 ± 0.3 1,616 ± 360
    35 789 ± 162 126 ± 19 6.2 ± 0.6 1,394 ± 218
P value
    8 0.25 0.15 0.90 0.04
    15 0.05 0.02 0.81 0.002
    22 0.26 0.25 0.30 0.04
    35 0.46 0.24 0.28 0.16

In-feed GOS modulates host immune response.

The immune responses were assessed in ileal and cecal tissues of trial 1 by quantification of the relative expressions of cytokine and chemokine genes representing the major inflammatory pathways of chickens (35). The relative expressions of the anti-inflammatory cytokine interleukin-10 (IL-10) and proinflammatory Th17-associated cytokine IL-17A were profoundly modulated in juvenile birds in both ileal and cecal tissues (Fig. 4; Table 3). In ileal tissues from GOS-fed birds, cytokine expression was marked by upregulation of IL-17A (fold change [FC] = 83; corresponding probability [Padj] = 0.002) at 8 da (Fig. 4A; Table 3) and downregulation of IL-10 (FC = 0.02; Padj = 0.002), while IL-17F remained unchanged (Padj = 0.836). At 15 da, the relative upregulation of ileal IL-17A (FC = 2841; Padj = 0.002) and IL-17F (FC = 19; Padj = 0.009) was recorded as a consequence of a reduction in expression in the control birds, while expression in the GOS-fed birds remained similar to that at 8 da (Fig. 4B). In cecal tissues the GOS-fed birds were also marked by downregulation of IL-10 (FC = 0.0001; Padj = 0.016) at 8 da and upregulation of IL-17A at 8, 15, and 35 da (FC ≥ 12; Padj = 0.005).

FIG 4.

FIG 4

Changes in expression of IL-17A, IL-17F, and IL-10 from ileal (A) and cecal (B) tissues. Relative gene expression was determined by quantitative RT-PCR from total RNAs extracted from cecal tissues for GOS-fed birds (gold) and compared to the expression from birds on the control diet (black). Expression of the gene of interest (GOI) relative to the housekeeping gene (HG) is presented as box-and-whisker plots of data from 7 independent birds determined from 3 technical replicates. The GOS-fed birds analyzed were reduced to 6 for the 15- and 35-da time points due to qPCR data not meeting quality thresholds. The housekeeping genes were the GAPDH and RPL4 genes. The data are recorded as log10-transformed 2−ΔCT values. The ΔCT was calculated (CT GOI − CT HG) for each sample; significant differences between 2−ΔCT values of the control and GOS diet cohorts of birds are indicated by P values above the sample pairs calculated using the nonparametric Wilcoxon rank sum test with Benjamini-Hochberg false-discovery rate correction.

TABLE 3.

Modulation of intestinal cytokine and chemokine responses to dietary GOS in broiler chickensa

Cytokine or chemokine Ileum
Cecum
8 da
15 da
22 da
35 da
8 da
15 da
22 da
35 da
FC Padj FC Padj FC Padj FC Padj FC Padj FC Padj FC Padj FC Padj
IFN-γ 0.5 0.8 1 0.8 1 0.8 3 0.8 0.5 0.6 7 0.2 2 0.9 1 0.9
IL-1β 0.6 0.7 0.3 0.5 0.8 0.9 5 0.5 0.6 0.9 2 0.9 0.4 0.9 3 0.9
IL-4 0.1 0.2 0.1 0.05 2 0.9 3 0.2 1 0.9 5 0.9 2.0 0.9 1 0.9
IL-10 0.02 0.002 2 0.8 0.6 0.3 2 0.8 0.001 0.02 6 0.4 0.5 0.7 0.4 0.7
IL-6 2 0.7 1 0.7 0.3 0.8 0.3 0.2 0.04 0.5 13 0.1 0.3 0.5 1 0.6
ChCXCLi-1 0.7 0.8 2 0.4 16 0.03 2 0.4 0.9 0.9 1 0.9 0.05 0.07 1 0.9
ChCXCLi-2 2 0.4 4 0.2 15 0.1 2 0.4 1 0.7 3 0.5 0.1 0.1 1 0.5
IL-17A 83 0.002 2841 0.002 0.6 0.6 0.6 0.8 12 0.005 88 0.005 11 0.1 60 0.005
IL-17F 0.8 0.8 19 0.009 0.8 0.8 1.1 0.8 0.2 0.1 0.7 1 0.3 0.9 1 0.9
a

Cytokine and chemokine gene expression is recorded as fold change (FC) for GOS-fed birds relative to the control diet birds at the same age calculated as 2−ΔΔCT. Corresponding probabilities (Padj) were calculated from log10-transformed 2−ΔCT values using nonparametric Wilcoxon rank sum tests adjusted with Benjamini-Hochberg false-discovery rate correction.

At 22 da in GOS-fed birds, proinflammatory chemokine ChCXCLi-1 was increased in the ileum (FC = 16; Padj = 0.03) and, conversely, reduced in the ceca (FC = 0.05; Padj = 0.07). These observations indicate that the GOS diet or concomitant shifts in the gut microbiota do not drive induction of proinflammatory responses such as IL-1β or Th1-associated gamma interferon (IFN-γ) cytokines, while the reduction of IL-4, a marker for the Th2 pathway, was transient and limited to the ileum at 15 da (FC = 0.1; Padj = 0.05).

Figure 5 shows the relative expressions of the IL-17A, IL-17F, and IL-10 genes in the ileum and ceca of 8-da chicks on GOS or control feed. Birds on the GOS and control diets were clearly differentiated on the basis of these data and demonstrated a reduction in the variation in transcription of these specific cytokines in the ceca of birds provided with GOS feed. The increase of IL-17A transcription in the ileal tissues of GOS-fed birds at 8 da coincides with reduced expression of IL-10 (Fig. 5A), whereas IL-17F transcripts were unaffected (Fig. 5B and C). Similarly, the in-feed inclusion of GOS resulted in higher levels of IL-17A and reduced levels of IL-10 transcription in cecal tissues (Fig. 5D) without modulation of IL-17F transcription (Fig. 5E and F). These data suggest differential regulation of IL-17A and IL-17F and that IL-17A responds to in-feed GOS as a component of the Th17 immune response in the ceca, which coincides with the greater relative abundance of L. johnsonii (OTU0010).

FIG 5.

FIG 5

Differential cytokine gene expression in juvenile cecal and ileal tissues. Shown is juvenile IL-17A, IL-17F, and IL-10 differential gene expression relative to those of GAPDH and RPL4 at 8 da in ileal (A, B, and C) and cecal (D, E, and F) tissues of birds on the GOS diet compared to those on the control diet. The 2−ΔCT was determined as indicated in the legend to Fig. 4, and the log10-transformed expression values were plotted against each other (n = 7).

Abundance of L. johnsonii in the cecal lumen positively correlates with bird growth performance.

Correlations between abundances of the Lactobacillus isolates with bird weight were analyzed by combining all the data for 35-da birds from trials 1, 4, 5, and 6, which represent a range of performance outcomes. These data show a clear positive relationship between body mass and the L. johnsonii genome copy number determined by quantitative PCR (qPCR) from the cecal microbiota (Pearson’s r = 0.876; P ≤ 0.001 [Fig. 6A]). A significant negative correlation between L. crispatus genome copy number and mass was also observed (Pearson’s r = −0.763; P ≤ 0.001 [data not shown]). The abundances of L. crispatus and L. johnsonii were further analyzed for any relationship with the expression of IL-17A, IL-17F, and IL-10 that we observed to exhibit differential expression on the GOS diet. Figure 6B shows the correlation noted with the expression of IL-17A and L. johnsonii genome copy number (Pearson’s r = 0.502; P = 0.003). These results together strongly suggest that L. johnsonii acts as a key species promoted by GOS to improve growth performance and prime a Th17 immune response.

FIG 6.

FIG 6

Correlation of growth performance to L. johnsonii abundance and IL-17A expression. Panel A shows the Pearson correlation of bird mass at 35 da against log10 L. johnsonii gene copy number per gram of cecal contents determined by quantitative PCR from DNA extracted from cecal contents. Panel B shows the Pearson correlation of the bird weights at 35 da with the cecal IL-17A transcription levels expressed as log10-transformed 2−ΔCT values. Gene expression was determined by RT-qPCR from total RNAs extracted from cecal tissues.

Modulation of cecal lactobacilli and bird growth performance.

To examine if shifts in the cecal abundance of lactobacilli of juvenile broiler chickens can modify growth performance, we administered either L. crispatus DC21.1 or L. johnsonii DC22.2 (8 log10 CFU) by cloacal gavage to chicks at 6 da. Cloacal gavage has the advantage of allowing cecal colonization without the impact of upper intestinal transit and accompanying losses in the effective dose of the colonizing bacteria (36). Figure 7A shows marked shifts in the cecal abundance ratios of L. crispatus/L. johnsonii (competitive indices calculated as the ratios of the genome copy numbers per gram of cecal content) at 35 da in favor of the Lactobacillus spp. administered compared to the nontreated controls for birds on control or GOS diets. Extreme differences in the cecal abundance of L. johnsonii corresponded with disparate differences in the weights of mature birds at 35 da. The mean body weight of the birds with low cecal L. johnsonii abundance (administered with competitive L. crispatus) fed on the control diet was 1.86 ± 0.16 kg, compared with 2.83 ± 0.11 kg for the birds with high cecal L. johnsonii abundance (P < 0.001). Figure 7B and C show the respective correlations between body mass and L. johnsonii genome copy number from the cecal microbiota of birds administered either L. johnsonii DC22.2 (Pearson’s r = 0.353; P = 0.038) or L. crispatus DC21.1 (Pearson’s r = 0.504; P < 0.001). These data provide further evidence for the positive relationship between the cecal abundance of L. johnsonii and growth performance. The impact of the early exogenous introduction of L. crispatus DC21.1 was to reduce the abundance of L. johnsonii, which coincided with a reduction in the mean body mass of the birds at 35 da. Although the provision of in-feed GOS under these circumstances led to an increase in the relative abundance of cecal L. johnsonii and improved body masses at 35 da, the birds in the L. crispatus treatment groups did not develop a comparable relative abundance of L. johnsonii or achieve the weight at 35 da observed for mock-treated birds (Fig. 7C). Collectively, these data indicate L. crispatus is a competitor of L. johnsonii that affects differences in the compositional development of the cecal microbiota. Early shifts in the juvenile microbiota have a profound effect on the weights of market-ready broiler chickens. Figure 7C shows that the impact of dietary GOS is greatest on the weaker-performing birds administered L. crispatus, with increased body weight and increased cecal L. johnsonii abundance relative to those on the control diet due to expansion of the niche available to the resident bacteria.

FIG 7.

FIG 7

Modulation of the juvenile cecal microbiota. Panel A shows the competitive indices (L. crispatus/L. johnsonii ratios) at 35 da of broiler chickens either nontreated or administered 8 log10 CFU of either L. crispatus DC21.1 or L. johnsonii DC22.2 by cloacal gavage at 6 da. Competitive indices were calculated as the ratios of L. crispatus (OTU0006) to L. johnsonii (OTU0010) genome copy numbers per gram of cecal content determined by qPCR. Panel B shows the Pearson correlation of bird mass at 35 da against L. johnsonii gene copy number per gram of cecal content in birds administered L. johnsonii. Panel C shows the Pearson correlation of bird mass at 35 da against L. johnsonii gene copy number per gram of cecal content in birds administered L. crispatus. The dashed horizontal line represents the contemporary male Ross 308 performance objective (96).

DISCUSSION

Improvements in the growth performance together with improved health are key goals in broiler chicken production. Studies of broiler chickens aimed to establish productive intestinal microbiota have highlighted compositional shifts in the microbiota that discriminate between birds with opposing zootechnical parameters, but these can vary between experimental trials (15). Several families of bacteria have been reported from the intestinal communities of chickens to show positive or negative associations with feed efficiency: Bacteroides, Enterobacteriaceae, Clostridium, Ruminococcus, Faecalibacterium, and Lactobacillus (15, 3739).

The inclusion of galacto-oligosaccharides in broiler feed resulted in an enhanced growth rate relative to those of chickens on carefully matched control diets reared under identical conditions. Prebiotic galacto-oligosaccharides have previously been reported to improve the performance and intestinal architecture and stimulate intestinal defenses of neonatal pigs (40). However, a GOS-supplemented diet fed to chickens increased fecal populations of bifidobacteria and lactobacilli but did not improve zootechnical performance (19). In contrast, we observed a significant improvement in performance of the GOS-fed broiler chickens that was also accompanied by changes in the intestinal microbiota. Differences in the abundance of specific members of the Lactobacillus genus in the cecal microbiota of juvenile birds on control and GOS diets were observed. Lactobacillus isolates were recovered from the cecal contents of these juvenile birds. Among these, specific isolates were identified that shared sequence identity with the OTUs displaying differential abundance in the microbiota of birds consuming either the GOS or the control diet. Whole-genome sequence alignments allowed the identification of L. johnsonii isolate DC22.2, prevalent in the ceca of GOS-fed birds, and L. crispatus isolate DC21.1, exhibiting greater abundance in control birds.

Lactobacilli need to import GOS (degree of polymerization of 2 to 6) and lactose since the enzymes required to break down the substrate are generally cell bound. Two principal pathways accomplish import: LacS lactose permease or the LacE/F phosphotransferase system, where the latter appears to be restricted to DP2 lactose (34). The dependence of LacS for the utilization of GOS with a DP of >2 was first established in L. acidophilus (41). Intestinal Lactobacillus species that form the “acidophilus complex” include L. crispatus, L. johnsonii, and L. helveticus, which show conservation of the gal-lac clusters (41). While the lacS gene is often present, the copresence of lacS and lacA (encoding β-galactosidase) appears to be associated with the ability to utilize GOS. L. johnsonii isolates exhibit host-specific differences, where human and porcine sources frequently possess the lacS and lacA genes but the poultry isolate FI9785 appears to be deficient due to genome rearrangements (42, 43). However, isolate FI9785 does contain orthologues of lacE/F. Converse to this, L. johnsonii DC22.2 has retained lacS and lacA but has lost the lacE/F genes. The L. johnsonii DC22.2 lacS permease gene contains a stop codon that would require initiation from an internal AUG with the loss of the first 31 amino acids based on comparisons with database homologues. However, notable exceptions to this are L. pasteuri and L. gallinarum, which, respectively, initiate translation at the corresponding position or 13 codons downstream. The syntenic position that harbors the lactose phosphotransferase-encoding genes in the L. johnsonii poultry isolate FI9785 (42) features a deletion in L. johnsonii DC22.2 that preserves the lacR gene encoding the repressor but dispenses with all the functional components. Paradoxically, in our experiments L. johnsonii DC22.2 did not efficiently utilize GOS in vitro but represented a greater differentially abundant component of the cecal microbiota of GOS-fed birds, which exhibited improved zootechnical performance. In contrast, L. crispatus DC21.1 can utilize GOS, but this did not provide a competitive advantage in GOS-fed chickens; rather, the reverse appears to be true. It seems unlikely that L. johnsonii DC22.2 can compete for the GOS substrate directly with L. crispatus DC21.1, which suggests that L. johnsonii DC22.2 benefits from the metabolic capability of another member of the cecal microbiota. The presence of GOS provides the trophic selection for members of the cecal community required to support autochthonous L. johnsonii. Indeed, a hallmark of the acidophilus complex gene contents is the absence of the biosynthetic pathways necessary to produce essential nutrients such as amino acids, purine nucleotides, and cofactors and therefore a reliance on effectively importing nutrients generated by the intestinal milieu (44, 45). Prebiotic selection in situ may well be a more reliable way of achieving a beneficial microbiota than directly providing dietary probiotics, as the response will be congruent with the metabolic capabilities of the resident community. Prevailing environmental conditions may alter the content and composition of the intestinal microbiota and therefore the outcomes of prebiotic selection. For example, members of the Bifidobacterium, Christensenella, and Lactobacillus genera have been reported to feature in the intestinal communities of chickens on GOS diets (19, 46, 47). However, removing GOS from the diet at 24 da and feeding the control finisher diet did not alter the performance improvement associated with feeding GOS to the juvenile birds or the succession of L. johnsonii in the process. This would suggest that the impact of juvenile prebiotic feed is lifelong. Recently, Slawinska et al. (48) have reported the delivery of galacto-oligosaccharides in ovo, which resulted in an increase in the relative abundance of Bifidobacterium-specific 16S rRNA PCR-amplifiable sequences from the cecal contents of mature birds at 42 da, implying that the composition of the mature microbiota can be programmed in early development.

The route to establishing a beneficial microbiota notwithstanding, we observed an increase in the abundance of L. johnsonii in GOS-fed birds that correlated with improved performance. L. johnsonii is an established probiotic with a variety of reported effects when administered to humans and animals. For example, L. johnsonii isolate N6.2 has been shown to have immunomodulatory effects in animal experiments and to protect diabetes-prone rats from developing the disease (49, 50). In another study, L. johnsonii was shown to attenuate respiratory viral infection via metabolic reprogramming and immune cell modulation (51). L. johnsonii LB1 expresses a bile salt hydrolase active against tauro-beta-muricholic acid (T-β-MCA), a critical mediator of farnesoid X receptor (FXR) signaling that is important in maintaining metabolic homeostasis (52). In broiler chickens, administration of an L. johnsonii isolate has been reported to improve growth performance (53). Subsequently, it was reported that meat from L. johnsonii-treated birds had higher nutritional value and the birds showed resistance to the development of necrotic enteritis (54, 55). Similar results were obtained by administering L. johnsonii LB1 to piglets to improve performance and reduce diarrhea (56). The administration of L. johnsonii FI9785 to broiler chickens has also been reported to reduce colonization by Clostridium perfringens, Escherichia coli O78:K80, and Campylobacter jejuni, which have a significant impact on poultry production (57, 58). Lactobacillus crispatus is also a recognized probiotic but is better known for its activity against recurrent urinary infections, bacterial vaginosis, and vaginal candidiasis (59). However, it should be noted that L. crispatus is commonly reported as a major constituent of the chicken microbiome (46, 60).

Shifts in the Lactobacillus spp. in response to GOS are accompanied by changes in the expression of cytokines and chemokines that have the potential to prime innate intestinal immune systems and enhance pathogen resistance. However, unchecked low-grade proinflammatory responses can cause tissue damage and inefficient feed conversion (61). Lactic acid, for example, is a by-product of glycolytic pathway of immune cells that can affect local T cell immunity by inhibiting T cell motility and inducing the change of CD4+ cells to a Th17 proinflammatory T cell subset, which leads to IL-17 production and chronic inflammation (62). However, lactic acid is also the homofermentative product of lactic acid bacteria such as L. johnsonii, the action of which in the gut has recently been reported to promote the expansion of intestinal stem cells, Paneth cells, and goblet cells (63). Coincident with the increased abundance of L. johnsonii, we observed significantly greater ileal goblet cell densities from juvenile birds on the GOS diet. We also observed an increase in IL-17A and a decrease in IL-10 gene expression in juvenile birds on the GOS diet. IL-17A has been proposed to promote the maintenance of intestinal epithelial cell integrity based on observations that IL-17A inhibition exacerbates colitis in a mouse model, which leads to weakening of the intestinal epithelial barrier (64). In contrast, IL-17F knockout mice are reported to be protected against chemically induced colitis, whereas IL-17A knockout mice remain sensitive (65). Moreover, IL-17F-deficient mice showed an increase in the colonic abundance of Clostridium cluster XIVa organisms that promote beneficial regulatory T cells and the expression of β-defensins 1 and 4 (65). Extrapolating from these data, we propose that the increased expression of IL-17A we observed without impact on IL-17F in GOS-fed chickens will promote gut health, a prerequisite for improved commercial production.

The induction of host Th17 responses in ileal and cecal tissues by an indigenous symbiont is reminiscent of the Th17 stimulation brought about by adherent segmented filamentous bacteria (SFB) described for mice (6668). The tight adherence of SFB to epithelial cells was observed to accelerate postnatal maturation of intestinal mucosal immunity by triggering a Th17 response (69). The observation of an intestinal Th17 response to tightly adherent symbiotes was extended to the human symbiont Bifidobacterium adolescentis in mice (70). However, the response arose through transcriptional program distinctly different from that observed for SFB, suggesting that intestinal Th17 responses are maintained by parallel sensor and signaling pathways. The upregulation of IL-17A in juvenile chickens fed a GOS diet may also support gut immune maturation through Th17 cell stimulation. In chickens, lactobacilli are recognized as adherent to the intestinal tract epithelium from crop to ceca. In addition to established cell adhesion factors, such as the expression of a fibronectin binding protein, it is proposed that L. johnsonii co-opts alternative cell surface-associated structures to cell adhesion roles; these include GroEL, elongation factor Tu, and lipoteichoic acid (7174).

Juvenile chickens have been reported to exhibit a transient IL-17 induction during the development of the natural microbiota (75). The study suggested that in the absence of IL-22, proinflammatory Th17 induction did not result in intestinal tissue damage. It is possible that IL-17 has a role in the codevelopment of the microbiota and innate immunity in chickens, which is consistent with our findings that upregulation of IL-17A did not cause lamina propria inflammation. Crhanova et al. (75) also reported the outcome of Salmonella enterica serovar Enteritidis challenge of chickens shifts from a Th1 response (induction of IFN-γ and nitric oxide synthase) at 1 to 4 da to a Th17 response at 16 da (induction of IL-17). They conclude that a mature Th17 subset of helper T cells produced IL-17 and IL-22, which confer resistance to S. Enteritidis infection and damage in older birds.

Conclusion.

We have demonstrated an increase in growth rate of broiler chickens in response to dietary supplementation with the prebiotic GOS. Juvenile chickens on GOS starter feed exhibited differences in the cecal abundance of key species of Lactobacillus compared to those on control feed. Differences in the cecal microbiota in early development correlated with the composition of the mature cecal microbiota and performance outcomes. The provision of dietary GOS increased the density of goblet cells populating ileal villi in the developing chicken gut. Goblet cell increases were accompanied by significant differences in the villus height and crypt depth at 15 da, a period when transitions in the development of the chicken microbiota from a juvenile to a mature composition are observed (7678). We have demonstrated a significant correlation between the market weight of chickens at 35 da and the cecal abundance of a specific L. johnsonii isolate identified as differentially abundant in the juvenile microbiota of GOS-fed birds. L. johnsonii abundance also shows a positive correlation with IL-17A gene expression. L. johnsonii is an established probiotic that has been demonstrated to have beneficial effects when applied in poultry production (5355, 57, 58). Several modes of action have been proposed for probiotic strains of L. johnsonii, but underlying these is the multimodal ability of the species to affect epithelial gut cell adherence (7174), which we propose will induce the expression of IL-17A. By taking a system-wide approach we have, for the first time, established mechanistic links between prebiotic selection of an autochthonous synbiotic species, increased IL-17A expression, and the development of the gut in healthy animals.

MATERIALS AND METHODS

Ethical approval.

Experiments involving the use of birds were subjected to an approval process under national guidelines by the United Kingdom Home Office. Work on this project was approved under United Kingdom Government Home Office project licensing ASPA 86. All project licenses are reviewed internally by the University Ethics Committee prior to submission to the Home Office. This includes the scrutiny of animal welfare, ethics, and handling.

Experimental birds.

Commercial male Ross 308 broiler chicks were obtained as hatchlings (PD Hook, Oxfordshire, UK). Birds were housed in a controlled environment under strict conditions of biosecurity. Temperatures were as outlined in the Code of Practice for the Housing and Care of Animals Bred, Supplied or Used for Scientific Purposes (79). Birds were provided feed and water ad libitum. Feeds were formulated on a least-cost basis and to meet the requirements set out in the Ross 308 Broiler Nutrition Specifications 2014 (80) and prepared by Target Feeds Ltd (Shropshire, UK). The diet regime was as follows: the control diet group was sustained on a wheat-based diet provided as a starter crumb for 0 to 10 days of age (da), grower pellets for 11 to 24 da, and finisher pellets for 25 to 35 da. The starter diet contained wheat (59.9% [wt/wt]), soya meal (32.5% [wt/wt]), soyabean oil (3.65% [wt/wt]), limestone (0.6% [wt/wt]), calcium phosphate (1.59% [wt/wt]), sodium bicarbonate (0.27% [wt/wt]), the enzymes phytase and xylanase (dosed according to the manufacturer’s instructions; DSM Nutritional Products Ltd., Basel, Switzerland), and a vitamin mix containing salt, lysine hydrochloride, dl-methionine, and threonine. The grower and finisher diets increased the wheat content at the expense of soya meal by 2 and 5% (wt/wt), respectively. GOS was provided as Nutrabiotic (GOS, 74% [wt/wt] dry matter) (Dairy Crest Ltd., Davidstow, Cornwall, UK). Galacto-oligosaccharide preparations contained a mixture of monosaccharides (glucose and galactose) and oligosaccharides (DP2 to DP8). The disaccharide lactose, a reactant in the manufacture of galacto-oligosaccharides, is not a galacto-oligosaccharide; all other disaccharides and longer oligosaccharides (DP3+) are considered to be galacto-oligosaccharides and nondigestible. The starter feed was supplemented with 3.37% (wt/wt) GOS and isocaloric adjustments made in the wheat (54% [wt/wt]) and soybean oil (4.88% [wt/wt]) contents. The grower and finisher feeds contained 1.685% GOS with respective adjusted wheat contents of 57.7% (wt/wt) and 63.3% (wt/wt) and soybean oil contents of 6.14% (wt/wt) and 6.22% (wt/wt). The final feeds were isocaloric (metabolizable energy including enzyme contribution) and contained the same crude protein levels and Degussa poultry digestible amino acid values (lysine, methionine, methionine plus cysteine, threonine, tryptophan, isoleucine, valine, histidine, and arginine). The feed formulations are listed in Table S2.

TABLE S2

GOS and control feed formulations. Feed formulations for starter (0 to 10/11 days of age), grower (11/12 to 24 days of age), and finisher (25 to 35 days of age) diets are shown. Download Table S2, DOCX file, 0.02 MB (16KB, docx) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Chickens were euthanized by either exposure to rising CO2 gas or parenteral barbiturate overdose followed by cervical dislocation according to schedule 1 of the UK Animals (Scientific Procedures) Act. The birds were weighed before tissue and intestinal contents were sampled postmortem. Ileal tissues were sectioned from approximately 3 cm distal to Meckel’s diverticulum, and cecal tissues were collected from the distal tips of the ceca. Intestinal tissues were immediately frozen in liquid nitrogen for subsequent RNA isolation or preserved in 10% (wt/vol) neutral buffered formalin (Fisher Scientific, Loughborough, UK) for histological assessment. Intestinal contents were collected and stored at –80°C until DNA isolation.

Trial designs. (i) GOS diet trial 1.

On the day of hatch, chicks were randomly assigned to either a control diet or a GOS-supplemented diet for the duration of the experiment. Two groups of 35 birds were kept in pens from day of hatch until day 6, when all birds were caged independently until euthanasia of 7 birds at sample time points 8, 15, and 22 days of age (da) to obtain intestinal contents and tissue biopsy specimens. Birds were weighed and feed consumption was recorded at least weekly from the start of the experiment at the day of hatch until then end of the study at 35 da. Growth rates between 8 and 35 da were determined for 10 birds remaining at the end of trial and for which feed consumption and live weights were recorded over the entire trial period. Feed conversion ratios (FCR) were calculated as a ratio of the cumulative feed consumed to the weights of the birds.

(ii) Ancillary GOS diet trials 2 and 3.

To advance the study, we modified the experimental design to establish if removing the prebiotic feed after the microbiota had been established in the juvenile birds could reproduce the beneficial effects on performance observed for mature birds. These studies used the starter and grower feed formulations listed in Table S3, but both GOS treatment and control birds in ancillary trial 2 and ancillary trial 3 were fed the control finisher diet 25 to 35 da. The organization of trial 2 was the same as that of trial 1 (n = 10), while for trial 3, the birds were cohoused on wood shavings in 10 pens of 3 birds and wing tagged to identify individual birds instead of individual caging. Feed consumption was measured per pen and calculated as the average per bird for each pen (n = 10).

TABLE S3

Primer sequences used for PCR. Download Table S3, DOCX file, 0.02 MB (18.9KB, docx) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

(iii) Cloacal gavage trials 4, 5, and 6.

On the day of hatch, chicks were randomly assigned to either the control or GOS-supplemented diet. At 6 da, axenic suspensions of either L. crispatus DC21.1 or L. johnsonii DC22.2 containing between 7.4 and 7.8 log10 CFU in 0.1 ml of MRD (Oxoid, Basingstoke, UK) were administered to chicks by cloacal gavage. Control groups were mock administered with MRD alone. Cloacal gavage was performed using a blunt narrow-nosed syringe to stimulate reverse peristalsis. Postgavage, experimental groups of 20 birds were housed in pairs and maintained on GOS or control diet (n = 10). The birds were fed either the control diet throughout or the GOS diet until 24 da and then switched to the control until the end of the trial at 35 da. Feed consumption was measured per pen and calculated as the average per bird for each pen.

Identification of lactic acid bacteria.

Cecal contents from each individual bird were serially diluted in MRD (Oxoid) and spread (0.1 ml) onto the surfaces of MRS (Oxoid) plates. The MRS plates were incubated under anaerobic conditions for 48 h at 37°C. The numbers of lactic acid bacterial colonies were recorded, and examples of distinct, well-isolated colonies were subcultured for identification and storage at –80°C. Multiple isolates from MRS plates were examined by microscopy using the Gram stain. Genomic DNAs were prepared from selected isolates showing different cell and colony morphologies using a GenElute bacterial genomic DNA kit (Sigma Aldridge, Gillingham, UK). Identification to presumptive species level was carried out by performing PCR amplification of 16S rRNA gene sequences using the primers 27f and 1522r (Table S3) (81, 82) and DNA sequencing of the products following cleanup (Wizard SV gel and PCR cleanup system; Promega, Southampton, Hampshire, UK) using dye terminator chemistry (Eurofins, Ebersberg, Germany). The 16S rRNA gene V4 region sequences were matched to the OTU clusters outputted from microbiome analysis. The genome sequences of L. crispatus DC21.1 and L. johnsonii DC22.2 were assembled using CLC Genomics Workbench 10.0.1 (Qiagen, Aarhus, Denmark) using a combination of data generated from the Illumina MiSeq and PacBio RSII platforms. The L. crispatus DC21.1 and L. johnsonii DC22.2 cultures were deposited at the National Collection of Industrial Food and Marine Bacteria (NCIMB) under the respective accession numbers 42771 and 42772.

In vitro growth of Lactobacillus on galacto-oligosaccharides.

To determine the ability of L. crispatus DC21.1 and L. johnsonii DC22.2 to utilize GOS in vitro, a purified Nutrabiotic GOS (74% [wt/wt] dry matter) containing a DP2+ lactose fraction was prepared using high-performance liquid chromatography (HPLC), with an Imtakt Unison UK-Amino (aminopropyl stationary phase) column (ARC Sciences, Oakham, UK) with acetonitrile-water mobile phase, to remove monomeric sugars (glucose and galactose) and lactose (IPOS Ltd., Huddersfield, UK). A reduced-carbon-source medium based on MRS broth with the omission of glucose was prepared as a basal medium (pH 6.7). One liter of the medium contained 10 g of tryptone (Oxoid), 5 g of yeast extract (Oxoid), 10 g of Lab-Lemco powder (Oxoid), 1 ml of sorbitan mono-oleate (Tween 80), 2 g of dipotassium hydrogen phosphate, 0.5 g of sodium acetate 3H2O, 2 g of diammonium hydrogen citrate, 0.2 g of magnesium sulfate 7H2O, and 0.05 g of manganese sulfate 4H2O (from Fisher Scientific unless otherwise stated). Each experiment was carried out using the basal medium with addition of DP2+ lactose GOS (0.5% [wt/vol]), together with a positive control, containing glucose (0.5% [wt/vol]) and a negative control with sterile water instead of the carbon source. The bacterial cultures were grown on MRS plates and suspended in the modified MRS medium to a density of 8 log10 CFU/ml (OD600 of approximately 1.5). The suspension was diluted 1 in 100 into the growth medium. The assay was carried out in triplicate with 3 technical replicates per biological replicate together with a set of uninoculated negative controls as blanks (0.2 ml in microtiter plates). The plates were covered and incubated at 37°C for 72 h under anaerobic conditions, with shaking. The OD600 obtained from growth on the basal medium, without the addition of a carbon source, was subtracted from the value of the growth on the selected carbon source.

Histology.

Tissue samples fixed in a 10% formalin solution were dehydrated through a series of alcohol solutions, cleared in xylene, and embedded in paraffin wax (Microtechnical Services Ltd., Exeter, UK). Sections (3 to 5 μm thick) were prepared and stained with either modified hematoxylin and eosin (H&E) or periodic acid-Schiff (PAS) using standard protocols. After staining, the slides were scanned with the NanoZoomer digital pathology system (Hamamatsu, Welwyn Garden City, UK). Measurements of villus height and crypt depth were made using the NanoZoomer digital pathology image program (Hamamatsu). Ten well-oriented villi per tissue section of 4 birds from each diet group at each sampling time were scanned at 40× resolution for each tissue sample. Villus height was measured from the tip of the villus to the crypt opening, and the associated crypt depth was measured from the base of the crypt to the level of the crypt opening. The ratio of villus height to relative crypt depth was calculated from these measurements. Goblet cells were enumerated from ileal sections stained with PAS. In one case the histology section did not fulfill the quality criterion of 10 well-oriented villi and was omitted from the analysis.

RNA isolation and RT-qPCR of cytokines and chemokines.

RNAs were isolated from cecum and ileum tissue biopsy specimens using a NucleoSpin RNA purification kit (Macherey-Nagel, GmbH & Co. KG, Düren, Germany) according to the manufacturer’s protocol, with the following modifications. Tissue samples were homogenized with the kit lysis buffer and 2.8-mm ceramic beads (MO BIO Laboratories Inc., Carlsbad, CA) using TissueLyser II (Qiagen, Hilden, Germany). Subsequently, total RNA was extracted as described in the protocol with a DNase I treatment step as per the manufacturer’s instructions. Purified RNAs were eluted in nuclease-free water, validated for quality and quantity using UV spectrophotometry (Nanodrop ND-1000; Labtech International Ltd., Uckfield, UK), and stored long term at –80°C. RNAs with OD260/OD280 ratios between 1.9 and 2.1 were deemed high quality; the sample ratios had a mean of 2.12 ± 0.01. Reverse transcription (RT) was performed with 1 μg of RNA, SuperScript II (Invitrogen Life Technologies, Carlsbad, CA), and random hexamers as described previously (76).

Quantitative PCR was performed with cDNA templates derived from 4 ng of total RNA in triplicate using SYBR green master mix (Applied Biosystems, Thermo Fisher Scientific, UK). The RNA level of expression was determined by qPCR using the Roche Diagnostics LightCycler 480 (Hoffmann La Roche AG, Switzerland). The primer sequences for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), RPL4, IFN-γ, IL-1β, IL-4, IL-6, IL-10, IL-17A, IL-17F, ChCXCLi-1, and ChCXCLi-2 (8386) are presented in Table S3. Cytokine and chemokine transcript levels and fold change were calculated according to the manufacturer’s recommendation using the 2−ΔCT and 2−ΔΔCT methods, where the CT is the PCR cycle threshold and ∆CT corresponds to the difference between the CT values of the cyto/chemokine gene and the reference housekeeping genes to give normalized transcript levels, and ∆∆CT is the difference between transcript levels of birds on the GOS and control diets (87). The means of triplicate CT values were used for analysis, where target gene CT values were normalized to those of the housekeeping GAPDH and 60S ribosomal protein L4 (RPL4) genes.

Microbiome analysis.

DNA was isolated from cecal contents using the MoBio PowerSoil kit (now Qiagen Ltd., Manchester, UK) according to the manufacturer’s instructions. For microbiome analysis the V4 regions of the bacterial 16S rRNA genes were PCR amplified using the primers 515f and 806r (Table S3) (88). Amplicons were then sequenced on the Illumina MiSeq platform using 2 × 250-bp cycles. The 16S rRNA gene sequences were quality filtered and clustered into OTUs in Mothur (89, 90) using the Schloss lab. MiSeq SOP (https://www.mothur.org/wiki/MiSeq_SOP, accessed 10 May 2018 [91]). Batch files of Mothur commands used in this study are available at https://github.com/PJRichards/Richards_GOS_broiler. Postprocessing rarefaction curves were plotted to assess sampling effort (Fig. S2).

FIG S2

Rarefaction curves indicating coverage of cecal bacterial communities. 16S rRNA gene bacterial communities from control diet-fed birds 8 to 35 days of age as indicated (black) (top) and GOS-supplemented-diet-fed birds 8 to 35 days of age as indicated (gold) (bottom). Download FIG S2, TIF file, 2.7 MB (2.7MB, tif) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Quantitative PCR enumeration of lactobacilli.

Quantitative PCR protocols to enumerate L. crispatus DC21.1 and L. johnsonii DC22.2 organisms from intestinal contents were developed by designing primers specific for the groEL gene sequences of these bacterial strains (Table S3). Real-time qPCR quantification of L. crispatus DC21.1 and L. johnsonii DC22.2 was performed with 1 μl of cecal content DNA (15 to 150 ng) using SYBR green master mix with the Roche Diagnostics LightCycler 480. The amplification conditions were denaturation at 95°C for 5 min followed by 45 cycles of 95°C for 15-s denaturation and 60°C for 1-min annealing. The fluorescence signals were measured at the end of each annealing step. Melting curves were generated by heating the samples from 65°C to 97°C at a ramp rate of 0.11°C per s. The data obtained were plotted against a standard curve generated with 5-fold serially diluted target bacterial DNAs. Genome copy number of target bacteria in each dilution was calculated based on its genome length and applied DNA quantity with the assumption of the mean molecular mass of one base pair as 650 Da. The method was validated first with DNA extracts from pure cultures of known CFU and then by spiking chicken cecal samples with increasing concentrations of target cells. The data were calculated as genome copy number per microliter of DNA applied in the PCR and converted into genome copy number per gram of cecal content based on the mass of cecal material and elution volume applied for DNA extraction.

Statistical analysis.

Growth rate was tested for significance by measuring the weight gain for each bird between 8 and 35 days and testing the difference between the growth rates (grams per day) using Student’s t test. Differences in bird mass at 35 days were compared using Student’s t test.

Competitive indices of the Lactobacillus species present in the ceca were calculated as the ratio of the L. crispatus (OTU0006) copy number per gram of cecal content to the L. johnsonii (OTU0010) copy number per gram of cecal content determined using qPCR.

For the microbiota β-diversity analysis, Bray-Curtis distances were tested for significance using analysis of molecular variance (AMOVA) implemented within Mothur (89). Linear discriminant analysis effect size (LefSe) (92) was also implemented within Mothur (89). Differences in α-diversity, Chao richness, and absolute abundance of Lactobacillus spp. were tested using Wilcoxon rank sum test. With the exception of Fig. 5, all figures were drawn using R version 3.6.1 (7 May 2019) (93) in Rstudio 1.2 (94). R scripts used to draw figures are available at https://github.com/PJRichards/Richards_GOS_broiler.

Significance tests of heterophil counts and villus and crypt measurements were performed using single-factor analysis of variance (ANOVA) with a P value of <0.05 used as the level significance. Non-normally distributed gene expression data were compared using the nonparametric Wilcoxon rank sum tests adjusted with the Benjamini-Hochberg false-discovery rate correction (95).

Data availability.

The genome DNA sequences of L. crispatus DC21.1 appear in the NCBI database under the accession numbers CP039266 to CP039267. The genome DNA sequences of L. johnsonii DC22.2 appear in the NCBI database under the accession numbers CP039261 to CP039265. Raw DNA sequence data and metadata in support of 16S rRNA metagenomic analysis appear in the NCBI database within Bioproject PRJNA380214. Raw zootechnical observations are available at https://github.com/PJRichards/Richards_GOS_broiler/tree/master/zootechnical.

ACKNOWLEDGMENTS

We acknowledge research funding from Dairy Crest Ltd. N.M.F. is a consultant to Dairy Crest Ltd.

REFERENCES

  • 1.Scanes CG. 2007. The global importance of poultry. Poult Sci 86:1057–1058. doi: 10.1093/ps/86.6.1057. [DOI] [PubMed] [Google Scholar]
  • 2.Mottet A, Tempio G. 2017. Global poultry production: current state and future outlook and challenges. Worlds Poult Sci J 73:245–256. doi: 10.1017/S0043933917000071. [DOI] [Google Scholar]
  • 3.de Vries M, de Boer I. 2010. Comparing environmental impacts for livestock products: a review of life cycle assessments. Livestock Sci 128:1–11. doi: 10.1016/j.livsci.2009.11.007. [DOI] [Google Scholar]
  • 4.Zuidhof M, Schneider B, Carney V, Korver D, Robinson F. 2014. Growth, efficiency, and yield of commercial broilers from 1957, 1978, and 2005. Poult Sci 93:2970–2982. doi: 10.3382/ps.2014-04291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tallentire C, Leinonen I, Kyriazakis I. 2018. Artificial selection for improved energy efficiency is reaching its limits in broiler chickens. Sci Rep 8:1168. doi: 10.1038/s41598-018-19231-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Castanon J. 2007. History of the use of antibiotic as growth promoters in European poultry feeds. Poult Sci 86:2466–2471. doi: 10.3382/ps.2007-00249. [DOI] [PubMed] [Google Scholar]
  • 7.Van Immerseel F, Eeckhaut V, Moore R, Choct M, Ducatelle R. 2017. Beneficial microbial signals from alternative feed ingredients: a way to improve sustainability of broiler production? Microb Biotechnol 10:1008–1011. doi: 10.1111/1751-7915.12794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yadav S, Jha R. 2019. Strategies to modulate the intestinal microbiota and their effects on nutrient utilization, performance, and health of poultry. J Anim Sci Biotechnol 10:2. doi: 10.1186/s40104-018-0310-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sethiya N. 2016. Review on natural growth promoters available for improving gut health of poultry: an alternative to antibiotic growth promoters. Asian J Poultry Sci 10:1–29. doi: 10.3923/ajpsaj.2016.1.29. [DOI] [Google Scholar]
  • 10.Thacker P. 2013. Alternatives to antibiotics as growth promoters for use in swine production: a review. J Anim Sci Biotechnol 4:35. doi: 10.1186/2049-1891-4-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Huang P, Zhang Y, Xiao K, Jiang F, Wang H, Tang D, Liu D, Liu B, Liu Y, He X, Liu H, Liu X, Qing Z, Liu C, Huang J, Ren Y, Yun L, Yin L, Lin Q, Zeng C, Su X, Yuan J, Lin L, Hu N, Cao H, Huang S, Guo Y, Fan W, Zeng J. 2018. The chicken gut metagenome and the modulatory effects of plant-derived benzylisoquinoline alkaloids. Microbiome 6:211. doi: 10.1186/s40168-018-0590-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Erickson K, Hubbard N. 2000. Probiotic immunomodulation in health and disease. J Nutr 130:403S–409S. doi: 10.1093/jn/130.2.403S. [DOI] [PubMed] [Google Scholar]
  • 13.Gadde U, Kim W, Oh S, Lillehoj H. 2017. Alternatives to antibiotics for maximizing growth performance and feed efficiency in poultry: a review. Anim Health Res Rev 18:26–45. doi: 10.1017/S1466252316000207. [DOI] [PubMed] [Google Scholar]
  • 14.Schokker D, Jansman A, Veninga G, De Bruin N, Vastenhouw S, de Bree F, Bossers A, Rebel J, Smits M. 2017. Perturbation of microbiota in one-day old broiler chickens with antibiotic for 24 hours negatively affects intestinal immune development. BMC Genomics 18:241. doi: 10.1186/s12864-017-3625-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Stanley D, Hughes R, Geier M, Moore R. 2016. Bacteria within the gastrointestinal tract microbiota correlated with improved growth and feed conversion: challenges presented for the identification of performance enhancing probiotic bacteria. Front Microbiol 7:187. doi: 10.3389/fmicb.2016.00187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rubio L. 2019. Possibilities of early life programming in broiler chickens via intestinal microbiota modulation. Poult Sci 98:695–706. doi: 10.3382/ps/pey416. [DOI] [PubMed] [Google Scholar]
  • 17.van Leeuwen SS, Kuipers BJH, Dijkhuizen L, Kamerling JP. 2016. Comparative structural characterization of 7 commercial galacto-oligosaccharide (GOS) products. Carbohydr Res 425:48–58. doi: 10.1016/j.carres.2016.03.006. [DOI] [PubMed] [Google Scholar]
  • 18.Van Bueren A, Mulder M, Van Leeuwen S, Dijkhuizen L. 2017. Prebiotic galactooligosaccharides activate mucin and pectic galactan utilization pathways in the human gut symbiont Bacteroides thetaiotaomicron. Sci Rep 7:40478. doi: 10.1038/srep40478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Jung S, Houde R, Baurhoo B, Zhao X, Lee B. 2008. Effects of galacto-oligosaccharides and a Bifidobacteria [sic] lactis-based probiotic strain on the growth performance and fecal microflora of broiler chickens. Poult Sci 87:1694–1699. doi: 10.3382/ps.2007-00489. [DOI] [PubMed] [Google Scholar]
  • 20.Bednarczyk M, Stadnicka K, Kozłowska I, Abiuso C, Tavaniello S, Dankowiakowska A, Sławińska A, Maiorano G. 2016. Influence of different prebiotics and mode of their administration on broiler chicken performance. Animal 10:1271–1279. doi: 10.1017/S1751731116000173. [DOI] [PubMed] [Google Scholar]
  • 21.Choct M. 2009. Managing gut health through nutrition. Br Poult Sci 50:9–15. doi: 10.1080/00071660802538632. [DOI] [PubMed] [Google Scholar]
  • 22.Kraehenbuhl J-P, Neutra M. 1992. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev 72:853–879. doi: 10.1152/physrev.1992.72.4.853. [DOI] [PubMed] [Google Scholar]
  • 23.Honda K, Littman D. 2012. The microbiome in infectious disease and inflammation. Annu Rev Immunol 30:759–795. doi: 10.1146/annurev-immunol-020711-074937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, Yagita H, Ishii N, Evans R, Honda K, Takeda K. 2008. ATP drives lamina propria Th 17 cell differentiation. Nature 455:808–812. doi: 10.1038/nature07240. [DOI] [PubMed] [Google Scholar]
  • 25.Ivanov I, de Llanos Frutos R, Manel N, Yoshinaga K, Rifkin D, Sartor R, Finlay B, Littman D. 2008. Specific microbiota direct the differentiation of Il-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337–349. doi: 10.1016/j.chom.2008.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jian W, Zhu L, Dong X. 2001. New approach to phylogenetic analysis of the genus Bifidobacterium based on partial hsp60 gene sequences. Int J Syst Evol Microbiol 51:1633–1638. doi: 10.1099/00207713-51-5-1633. [DOI] [PubMed] [Google Scholar]
  • 27.Junick J, Blaut M. 2012. Quantification of human fecal Bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl Environ Microbiol 78:2613–2622. doi: 10.1128/AEM.07749-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ojala T, Kankainen M, Castro J, Cerca N, Edelman S, Westerlund-Wikström B, Paulin L, Holm L, Auvinen P. 2014. Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis. BMC Genomics 15:1070. doi: 10.1186/1471-2164-15-1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Dertli E, Colquhoun I, Gunning A, Bongaerts R, Le Gall G, Bonev B, Mayer M, Narbad A. 2013. Structure and biosynthesis of two exopolysaccharides produced by Lactobacillus johnsonii FI9785. J Biol Chem 288:31938–31951. doi: 10.1074/jbc.M113.507418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.O’Flaherty S, Crawley A, Theriot C, Barrangou R. 2018. The Lactobacillus bile salt hydrolase repertoire reveals niche-specific adaptation. mSphere 3:e00140-18. doi: 10.1128/mSphere.00140-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ventura M, Jankovic I, Walker D, Pridmore R, Zink R. 2002. Identification and characterization of novel surface proteins in Lactobacillus johnsonii and Lactobacillus gasseri. Appl Environ Microbiol 68:6172–6181. doi: 10.1128/aem.68.12.6172-6181.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sillanpää J, Martínez B, Antikainen J, Toba T, Kalkkinen N, Tankka S, Lounatmaa K, Keränen J, Höök M, Westerlund-Wikström B, Pouwels PH, Korhonen TK. 2000. Characterization of the collagen-binding S-layer protein CbsA of Lactobacillus crispatus. J Bacteriol 182:6440–6450. doi: 10.1128/jb.182.22.6440-6450.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Antikainen J, Anton L, Sillanpää J, Korhonen T. 2002. Domains in the S-layer protein CbsA of Lactobacillus crispatus involved in adherence to collagens, laminin and lipoteichoic acids and in self-assembly. Mol Microbiol 46:381–394. doi: 10.1046/j.1365-2958.2002.03180.x. [DOI] [PubMed] [Google Scholar]
  • 34.Gänzle M, Follador R. 2012. Metabolism of oligosaccharides and starch in lactobacilli: a review. Front Microbiol 3:340. doi: 10.3389/fmicb.2012.00340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kaiser P, Stäheli P. 2014. Avian cytokines and chemokines, p 189–204. In Schat KA, Kaspers B, Kaiser P (ed), Avian immunology, 2nd ed Academic Press, San Diego, CA. [Google Scholar]
  • 36.Arsi K, Donoghue A, Woo-Ming A, Blore P, Donoghue D. 2015. Intracloacal inoculation, an effective screening method for determining the efficacy of probiotic bacterial isolates against Campylobacter colonization in broiler chickens. J Food Prot 78:209–213. doi: 10.4315/0362-028X.JFP-14-326. [DOI] [PubMed] [Google Scholar]
  • 37.Singh KM, Shah TM, Reddy B, Deshpande S, Rank DN, Joshi CG. 2014. Taxonomic and gene-centric metagenomics of the fecal microbiome of low and high feed conversion ratio (FCR) broilers. J Appl Genet 55:145–154. doi: 10.1007/s13353-013-0179-4. [DOI] [PubMed] [Google Scholar]
  • 38.Yan W, Sun C, Yuan J, Yang N. 2017. Gut metagenomic analysis reveals prominent roles of Lactobacillus and cecal microbiota in chicken feed efficiency. Sci Rep 7:45308. doi: 10.1038/srep45308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Siegerstetter S-C, Schmitz-Esser S, Magowan E, Wetzels SU, Zebeli Q, Lawlor PG, O’Connell NE, Metzler-Zebeli BU. 2017. Intestinal microbiota profiles associated with low and high residual feed intake in chickens across two geographical locations. PLoS One 12:e0187766. doi: 10.1371/journal.pone.0187766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Alizadeh A, Akbari P, Difilippo E, Schols H, Ulfman L, Schoterman M, Garssen J, Fink-Gremmels J, Braber S. 2016. The piglet as a model for studying dietary components in infant diets: effects of galacto-oligosaccharides on intestinal functions. Br J Nutr 115:605–618. doi: 10.1017/S0007114515004997. [DOI] [PubMed] [Google Scholar]
  • 41.Andersen J, Barrangou R, Hachem M, Lahtinen S, Goh Y, Svensson B, Klaenhammer T. 2011. Transcriptional and functional analysis of galactooligosaccharide uptake by lacS in Lactobacillus acidophilus. Proc Natl Acad Sci U S A 108:17785–17790. doi: 10.1073/pnas.1114152108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wegmann U, Overweg K, Horn N, Goesmann A, Narbad A, Gasson M, Shearman C. 2009. Complete genome sequence of Lactobacillus johnsonii FI9785, a competitive exclusion agent against pathogens in poultry. J Bacteriol 191:7142–7143. doi: 10.1128/JB.01182-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Guinane CM, Kent RM, Norberg S, Hill C, Fitzgerald GF, Stanton C, Ross RP. 2011. Host specific diversity in Lactobacillus johnsonii as evidenced by a major chromosomal inversion and phage resistance mechanisms. PLoS One 6:e18740. doi: 10.1371/journal.pone.0018740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Pridmore R, Berger B, Desiere F, Vilanova D, Barretto C, Pittet A-C, Zwahlen M-C, Rouvet M, Altermann E, Barrangou R, Mollet B, Mercenier A, Klaenhammer T, Arigoni F, Schell M. 2004. The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. Proc Natl Acad Sci U S A 101:2512–2517. doi: 10.1073/pnas.0307327101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Altermann E, Russell W, Azcarate-Peril M, Barrangou R, Buck B, McAuliffe O, Souther N, Dobson A, Duong T, Callanan M, Lick S, Hamrick A, Cano R, Klaenhammer T. 2005. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc Natl Acad Sci U S A 102:3906–3912. doi: 10.1073/pnas.0409188102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Azcarate-Peril MA, Butz N, Cadenas MB, Koci M, Ballou A, Mendoza M, Ali R, Hassan H, Azcarate-Peril MA, Butz N, Cadenas MB, Koci M, Ballou A, Mendoza M, Ali R, Hassan H. 2018. An attenuated Salmonella enterica serovar Typhimurium strain and galacto-oligosaccharides accelerate clearance of Salmonella infections in poultry through modifications to the gut microbiome. Appl Environ Microbiol 84:e02526-17. doi: 10.1128/AEM.02526-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hughes RA, Ali RA, Mendoza MA, Hassan HM, Koci MD. 2017. Impact of dietary galacto-oligosaccharide (GOS) on chicken’s gut microbiota, mucosal gene expression, and Salmonella colonization. Front Vet Sci 4:192. doi: 10.3389/fvets.2017.00192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Slawinska A, Dunislawska A, Plowiec A, Radomska M, Lachmanska J, Siwek M, Tavaniello S, Maiorano G. 2019. Modulation of microbial communities and mucosal gene expression in chicken intestines after galactooligosaccharides delivery in ovo. PLoS One 14:e0212318. doi: 10.1371/journal.pone.0212318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Valladares R, Sankar D, Li N, Williams E, Lai K, Abdelgeliel A, Gonzalez C, Wasserfall C, Larkin IIJ, Schatz D, Atkinson M, Triplett E, Neu J, Lorca G. 2010. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 5:e10507. doi: 10.1371/journal.pone.0010507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Marcial G, Ford A, Haller M, Gezan S, Harrison N, Cai D, Meyer J, Perry D, Atkinson M, Wasserfall C, Garrett T, Gonzalez C, Brusko T, Dahl W, Lorca G. 2017. Lactobacillus johnsonii N6.2 modulates the host immune responses: a double-blind, randomized trial in healthy adults. Front Immunol 8:655. doi: 10.3389/fimmu.2017.00655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Fonseca W, Lucey K, Jang S, Fujimura K, Rasky A, Ting H-A, Petersen J, Johnson C, Boushey H, Zoratti E, Ownby D, Levine A, Bobbit K, Lynch S, Lukacs N. 2017. Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation. Mucosal Immunol 10:1569–1580. doi: 10.1038/mi.2017.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.DiMarzio M, Rusconi B, Yennawar N, Eppinger M, Patterson A, Dudley E. 2017. Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-β-MCA. PLoS One 12:e0183564. doi: 10.1371/journal.pone.0183564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wang H, Ni X, Qing X, Zeng D, Luo M, Liu L, Li G, Pan K, Jing B. 2017. Live probiotic Lactobacillus johnsonii BS15 promotes growth performance and lowers fat deposition by improving lipid metabolism, intestinal development, and gut microflora in broilers. Front Microbiol 8:1073. doi: 10.3389/fmicb.2017.01073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wang H, Ni X, Liu L, Zeng D, Lai J, Qing X, Li G, Pan K, Jing B. 2017. Controlling of growth performance, lipid deposits and fatty acid composition of chicken meat through a probiotic, Lactobacillus johnsonii during subclinical Clostridium perfringens infection. Lipids Health Dis 16:38. doi: 10.1186/s12944-017-0408-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Qing X, Zeng D, Wang H, Ni X, Liu L, Lai J, Khalique A, Pan K, Jing B. 2017. Preventing subclinical necrotic enteritis through Lactobacillus johnsonii bs15 by ameliorating lipid metabolism and intestinal microflora in broiler chickens. AMB Express 7:139. doi: 10.1186/s13568-017-0439-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Xin J, Zeng D, Wang H, Sun N, Zhao Y, Dan Y, Pan K, Jing B, Ni X. 7 January 2019. Probiotic Lactobacillus johnsonii BS15 promotes growth performance, intestinal immunity, and gut microbiota in piglets. Probiotics Antimicrob Proteins doi: 10.1007/s12602-018-9511-y. [DOI] [PubMed] [Google Scholar]
  • 57.La Ragione R, Narbad A, Gasson M, Woodward M. 2004. In vivo characterization of Lactobacillus johnsonii FI9785 for use as a defined competitive exclusion agent against bacterial pathogens in poultry. Lett Appl Microbiol 38:197–205.56. doi: 10.1111/j.1472-765x.2004.01474.x. [DOI] [PubMed] [Google Scholar]
  • 58.Mañes-Lázaro R, Van Diemen PM, Pin C, Mayer MJ, Stevens MP, Narbad A. 2017. Administration of Lactobacillus johnsonii FI9785 to chickens affects colonisation by Campylobacter jejuni and the intestinal microbiota. Br Poult Sci 58:373–381. doi: 10.1080/00071668.2017.1307322. [DOI] [PubMed] [Google Scholar]
  • 59.Hütt P, Lapp E, Štšepetova J, Smidt I, Taelma H, Borovkova N, Oopkaup H, Ahelik A, Rööp T, Hoidmets D, Samuel K, Salumets A, Mändar R. 2016. Characterisation of probiotic properties in human vaginal lactobacilli strains. Microb Ecol Health Dis 27:30484. doi: 10.3402/mehd.v27.30484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Stanley D, Geier M, Chen H, Hughes R, Moore R. 2015. Comparison of fecal and cecal microbiotas reveals qualitative similarities but quantitative differences. BMC Microbiol 15:51. doi: 10.1186/s12866-015-0388-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Kogut M, Genovese K, Swaggerty C, He H, Broom L. 2018. Inflammatory phenotypes in the intestine of poultry: not all inflammation is created equal. Poult Sci 97:2339–2346. doi: 10.3382/ps/pey087. [DOI] [PubMed] [Google Scholar]
  • 62.Haas R, Smith J, Rocher-Ros V, Nadkarni S, Montero-Melendez T, D'Acquisto F, Bland EJ, Bombardieri M, Pitzalis C, Perretti M, Marelli-Berg FM, Mauro C. 2015. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol 13:e1002202. doi: 10.1371/journal.pbio.1002202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Lee Y-S, Kim T-Y, Kim Y, Lee S-H, Kim S, Kang SW, Yang J-Y, Baek I-J, Sung YH, Park Y-Y, Hwang SW, O E, Kwang S, Liu S, Kamada N, Gao N, Kweon M-N. 2018. Microbiota-derived lactate accelerates intestinal stem-cell-mediated epithelial development. Cell Host Microbe 24:833–846. doi: 10.1016/j.chom.2018.11.002. [DOI] [PubMed] [Google Scholar]
  • 64.Maxwell J, Zhang Y, Brown W, Smith C, Byrne F, Fiorino M, Stevens E, Bigler J, Davis J, Rottman J, Budelsky A, Symons A, Towne J. 2015. Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation. Immunity 43:739–750. doi: 10.1016/j.immuni.2015.08.019. [DOI] [PubMed] [Google Scholar]
  • 65.Tang C, Kakuta S, Shimizu K, Kadoki M, Kamiya T, Shimazu T, Kubo S, Saijo S, Ishigame H, Nakae S, Iwakura Y. 2018. Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing T reg cells through modification of the intestinal microbiota. Nat Immunol 19:755–765. doi: 10.1038/s41590-018-0134-y. [DOI] [PubMed] [Google Scholar]
  • 66.Ivanov I, Atarashi K, Manel N, Brodie E, Shima T, Karaoz U, Wei D, Goldfarb K, Santee C, Lynch S, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman D. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498. doi: 10.1016/j.cell.2009.09.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Schnupf P, Gaboriau-Routhiau V, Gros M, Friedman R, Moya-Nilges M, Nigro G, Cerf-Bensussan N, Sansonetti P. 2015. Growth and host interaction of mouse segmented filamentous bacteria in vitro. Nature 520:99–103. doi: 10.1038/nature14027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Schnupf P, Gaboriau-Routhiau V, Sansonetti P, Cerf-Bensussan N. 2017. Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world. Curr Opin Microbiol 35:100–109. doi: 10.1016/j.mib.2017.03.004. [DOI] [PubMed] [Google Scholar]
  • 69.Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-Bensussan N. 2009. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677–689. doi: 10.1016/j.immuni.2009.08.020. [DOI] [PubMed] [Google Scholar]
  • 70.Tan T, Sefik E, Geva-Zatorsky N, Kua L, Naskar D, Teng F, Pasman L, Ortiz-Lopez A, Jupp R, Wu H, Kasper D, Benoist C, Mathis D. 2016. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci U S A 113:E8141–E8150. doi: 10.1073/pnas.1617460113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Granato D, Perotti F, Masserey I, Rouvet M, Golliard M, Servin A, Brassart D. 1999. Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. Appl Environ Microbiol 65:1071–1077. doi: 10.1128/AEM.65.3.1071-1077.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Granato D, Bergonzelli G, Pridmore R, Marvin L, Rouvet M, Corthésy-Theulaz I. 2004. Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun 72:2160–2169. doi: 10.1128/iai.72.4.2160-2169.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Bergonzelli G, Granato D, Pridmore R, Marvin-Guy L, Donnicola D, Corthésy-Theulaz I. 2006. GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect Immun 74:425–434. doi: 10.1128/IAI.74.1.425-434.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Turpin W, Humblot C, Noordine M-L, Thomas M, Guyot J-P. 2012. Lactobacillaceae and cell adhesion: genomic and functional screening. PLoS One 7:e38034. doi: 10.1371/journal.pone.0038034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Crhanova M, Hradecka H, Faldynova M, Matulova M, Havlickova H, Sisak F, Rychlik I. 2011. Immune response of chicken gut to natural colonization by gut microflora and to Salmonella enterica serovar Enteritidis infection. Infect Immun 79:2755–2763. doi: 10.1128/IAI.01375-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Connerton PL, Richards PJ, Lafontaine GM, O’Kane PM, Ghaffar N, Cummings NJ, Smith DL, Fish NM, Connerton IF. 2018. The effect of the timing of exposure to Campylobacter jejuni on the gut microbiome and inflammatory responses of broiler chickens. Microbiome 6:88. doi: 10.1186/s40168-018-0477-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Johnson TJ, Youmans BP, Noll S, Cardona C, Evans NP, Karnezos TP, Ngunjiri JM, Abundo MC, Lee C-W, Johnson TJ, Youmans BP, Noll S, Cardona C, Evans NP, Karnezos TP, Ngunjiri JM, Abundo MC, Lee C-W. 2018. A consistent and predictable commercial broiler chicken bacterial microbiota in antibiotic-free production displays strong correlations with performance. Appl Environ Microbiol 84:e00362-18. doi: 10.1128/AEM.00362-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Ijaz UZ, Sivaloganathan L, McKenna A, Richmond A, Kelly C, Linton M, Stratakos AC, Lavery U, Elmi A, Wren BW, Dorrell N, Corcionivoschi N, Gundogdu O. 2018. Comprehensive longitudinal microbiome analysis of the chicken cecum reveals a shift from competitive to environmental drivers and a window of opportunity for Campylobacter. Front Microbiol 9:2452. doi: 10.3389/fmicb.2018.02452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Home Office. 2014. Code of practice for the housing and care of animals bred, supplied or used for scientific purposes. Home Office, London, United Kingdom. [Google Scholar]
  • 80.Aviagen. 2014. Ross 308 broiler nutrition specifications 2014. Aviagen, Huntsville, AL. [Google Scholar]
  • 81.Lane D. 1991. 16S/23S rRNA sequencing, p 115–175. In Stackebrandt E, Goodfellow M (ed), Nucleic acid techniques in bacterial systematics. Wiley, New York, NY. [Google Scholar]
  • 82.Ott S, Musfeldt M, Ullmann U, Hampe J, Schreiber S. 2004. Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora. J Clin Microbiol 42:2566–2572. doi: 10.1128/JCM.42.6.2566-2572.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Nang N, Lee J, Song B, Kang Y, Kim H, Seo S. 2011. Induction of inflammatory cytokines and Toll-like receptors in chickens infected with avian h9n2 influenza virus. Vet Res 42:64. doi: 10.1186/1297-9716-42-64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Grenier B, Schwartz-Zimmermann HE, Caha S, Moll WD, Schatzmayr G, Applegate TJ. 2015. Dose-dependent effects on sphingoid bases and cytokines in chickens fed diets prepared with Fusarium verticillioides culture material containing fumonisins. Toxins (Basel) 7:1253–1272. doi: 10.3390/toxins7041253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Reid WD, Close AJ, Humphrey S, Chaloner G, Lacharme-Lora L, Rothwell L, Kaiser P, Williams NJ, Humphrey TJ, Wigley P, Rushton SP. 2016. Cytokine responses in birds challenged with the human food-borne pathogen Campylobacter jejuni implies a Th17 response. R Soc Open Sci 3:150541. doi: 10.1098/rsos.150541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Rasoli M, Yeap SK, Tan SW, Moeini H, Ideris A, Bejo MH, Alitheen NB, Kaiser P, Omar AR. 2014. Alteration in lymphocyte responses, cytokine and chemokine profiles in chickens infected with genotype VII and VIII velogenic Newcastle disease virus. Comp Immunol Microbiol Infect Dis 37:11–21. doi: 10.1016/j.cimid.2013.10.003. [DOI] [PubMed] [Google Scholar]
  • 87.Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 88.Caporaso J, Lauber C, Walters W, Berg-Lyons D, Lozupone C, Turnbaugh P, Fierer N, Knight R. 2011. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A 108:4516–4522. doi: 10.1073/pnas.1000080107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Schloss P, Westcott S, Ryabin T, Hall J, Hartmann M, Hollister E, Lesniewski R, Oakley B, Parks D, Robinson C, Sahl J, Stres B, Thallinger G, Van Horn D, Weber C. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537–7541. doi: 10.1128/AEM.01541-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Westcott SL, Schloss PD, Westcott SL, Schloss PD. 2017. OptiClust, an improved method for assigning amplicon-based sequence data to operational taxonomic units. mSphere 2:e00073-17. doi: 10.1128/mSphereDirect.00073-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Kozich J, Westcott S, Baxter N, Highlander S, Schloss P. 2013. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq illumina sequencing platform. Appl Environ Microbiol 79:5112–5120. doi: 10.1128/AEM.01043-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. 2011. Metagenomic biomarker discovery and explanation. Genome Biol 12:R60. doi: 10.1186/gb-2011-12-6-r60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.R Core Team. 2019. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. [Google Scholar]
  • 94.RStudio Team. 2015. RStudio: integrated development environment for r. RStudio, Inc, Boston, MA. [Google Scholar]
  • 95.Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 57:289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x. [DOI] [Google Scholar]
  • 96.Aviagen Performance Objectives. 2014. Ross 308 broiler performance objectives. Aviagen Limited Newbridge, Scotland, United Kingdom. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

TABLE S1

Growth performance of broiler chickens raised on GOS-supplemented feed. Download Table S1, DOCX file, 0.03 MB (29.3KB, docx) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S1

Diversity of the cecal microbiota on GOS and control diets. Panels A to C show indices of α-diversity of cecal bacterial populations for broiler chickens on GOS (gold) and control (black/white) diets sampled through the rearing period (8 to 35 da). Panel D shows NMDS plots of Bray-Curtis dissimilarity indices for all birds at all sample days. Age-matched cecal microbial communities could not be distinguished at any time point (pairwise error rate [Bonferroni] > 0.0017). Download FIG S1, TIF file, 2.9 MB (2.9MB, tif) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S2

GOS and control feed formulations. Feed formulations for starter (0 to 10/11 days of age), grower (11/12 to 24 days of age), and finisher (25 to 35 days of age) diets are shown. Download Table S2, DOCX file, 0.02 MB (16KB, docx) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S3

Primer sequences used for PCR. Download Table S3, DOCX file, 0.02 MB (18.9KB, docx) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

FIG S2

Rarefaction curves indicating coverage of cecal bacterial communities. 16S rRNA gene bacterial communities from control diet-fed birds 8 to 35 days of age as indicated (black) (top) and GOS-supplemented-diet-fed birds 8 to 35 days of age as indicated (gold) (bottom). Download FIG S2, TIF file, 2.7 MB (2.7MB, tif) .

Copyright © 2020 Richards et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Data Availability Statement

The genome DNA sequences of L. crispatus DC21.1 appear in the NCBI database under the accession numbers CP039266 to CP039267. The genome DNA sequences of L. johnsonii DC22.2 appear in the NCBI database under the accession numbers CP039261 to CP039265. Raw DNA sequence data and metadata in support of 16S rRNA metagenomic analysis appear in the NCBI database within Bioproject PRJNA380214. Raw zootechnical observations are available at https://github.com/PJRichards/Richards_GOS_broiler/tree/master/zootechnical.


Articles from mSystems are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES